PER
Click for more information
5.26% 8.0¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-144

  1. samfiodiving
    4,103 Posts.
    lightbulb Created with Sketch. 1866
    clock Created with Sketch.
    10/06/21
    12:00
    Post #: 53765471
    Maybe so Akki

    But You cannot deny the unique situation we find ourselves in.

    and besides in comparison to the Roche Deal i believe i have compensated for this in my Scenario

    SEE HOW WE GO
    ANP Price at posting: 22.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.004(5.26%) 		Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $35.48K 451.2K

Buyers (Bids)

No. Vol. Price($)
1 12500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 198147 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.